Juxtapid Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Juxtapid
U
- Ubrelvy (ubrogepant)
- ubrogepant
- Uceris (budesonide)
- Ukoniq (umbralisib)
- Uloric (febuxostat)
- Ultracet (acetaminophen / tramadol)
- Ultram (tramadol)
- Ultram ER (tramadol)
- Ultram ODT (tramadol)
- umbralisib
- Umphamol (acetaminophen)
- UN-Aspirin Extra Strength (acetaminophen)
- Under Ten Care Infant (acetaminophen)
- Uni-Perr (acetaminophen / phenyltoloxamine)
- Uniretic (hydrochlorothiazide / moexipril)
- Uniserts (acetaminophen)
- Unisom PM Pain (acetaminophen / diphenhydramine)
- Univasc (moexipril)
- Up and Up Anti-Diarrheal Solution (loperamide)
- Uracil (doxycycline)
- Urelief Plus (butabarbital / hyoscyamine / phenazopyridine)
- Uricalm (phenazopyridine)
- Uricalm Intensive (acetaminophen / aspirin / caffeine)
- Urinary Analgesic (phenazopyridine)
- Uristat (phenazopyridine)
- Uristat Ultra (phenazopyridine)
- Uro-Pain (phenazopyridine)
- Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole)
- Urodol (phenazopyridine)
- Urogesic (phenazopyridine)
- Uroplus (sulfamethoxazole / trimethoprim)
- Uroplus DS (sulfamethoxazole / trimethoprim)
- Utibron Neohaler (glycopyrrolate / indacaterol)
More about Juxtapid (lomitapide)
- Juxtapid consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antihyperlipidemic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.